JP2004517128A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517128A5
JP2004517128A5 JP2002555749A JP2002555749A JP2004517128A5 JP 2004517128 A5 JP2004517128 A5 JP 2004517128A5 JP 2002555749 A JP2002555749 A JP 2002555749A JP 2002555749 A JP2002555749 A JP 2002555749A JP 2004517128 A5 JP2004517128 A5 JP 2004517128A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
nha
cycloalkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002555749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004517128A (ja
JP4280067B2 (ja
Filing date
Publication date
Priority claimed from SE0103650A external-priority patent/SE0103650D0/xx
Application filed filed Critical
Priority claimed from PCT/SE2002/000068 external-priority patent/WO2002055012A2/en
Publication of JP2004517128A publication Critical patent/JP2004517128A/ja
Publication of JP2004517128A5 publication Critical patent/JP2004517128A5/ja
Application granted granted Critical
Publication of JP4280067B2 publication Critical patent/JP4280067B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002555749A 2001-01-16 2002-01-15 治療用ヘテロ環式化合物 Expired - Fee Related JP4280067B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26210701P 2001-01-16 2001-01-16
SE0103650A SE0103650D0 (sv) 2001-11-01 2001-11-01 Therapeutic heterocyclic compounds
PCT/SE2002/000068 WO2002055012A2 (en) 2001-01-16 2002-01-15 Therapeutic heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2004517128A JP2004517128A (ja) 2004-06-10
JP2004517128A5 true JP2004517128A5 (enExample) 2009-03-05
JP4280067B2 JP4280067B2 (ja) 2009-06-17

Family

ID=26655583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002555749A Expired - Fee Related JP4280067B2 (ja) 2001-01-16 2002-01-15 治療用ヘテロ環式化合物

Country Status (15)

Country Link
US (4) US6812225B2 (enExample)
EP (1) EP1353913A2 (enExample)
JP (1) JP4280067B2 (enExample)
KR (2) KR100864356B1 (enExample)
CN (1) CN100509794C (enExample)
AR (2) AR035733A1 (enExample)
AU (1) AU2002217742B2 (enExample)
BR (1) BR0206512A (enExample)
CA (1) CA2434152A1 (enExample)
IL (1) IL156595A0 (enExample)
MX (1) MXPA03006250A (enExample)
NO (1) NO20033203L (enExample)
NZ (2) NZ535574A (enExample)
SA (1) SA02220710B1 (enExample)
WO (1) WO2002055012A2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000001793A (ko) * 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
NZ535574A (en) 2001-01-16 2006-07-28 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103649D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic quinoline compounds
SE0103648D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic quinolone compounds
US6963002B2 (en) * 2003-07-04 2005-11-08 Glenmark Pharmaceuticals Limited Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman
GB0322510D0 (en) * 2003-09-25 2003-10-29 Glaxo Group Ltd Novel compounds
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
EP2316458A1 (en) 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
US7767677B2 (en) 2004-09-20 2010-08-03 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
BRPI0614483A2 (pt) 2005-07-27 2011-03-29 Hoffmann La Roche ariloxiquinolinas e usos das mesmas como 5-ht6
WO2007053093A1 (en) * 2005-11-04 2007-05-10 Astrazeneca Ab Chroman compounds as 5 ht1b antagonists
UY29896A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
AR059356A1 (es) * 2006-02-14 2008-03-26 Astrazeneca Ab Nuevos radioligandos
WO2007097697A1 (en) * 2006-02-23 2007-08-30 Astrazeneca Ab Therapeutic quinoline compounds that are 5ht1b modulators
WO2008142623A2 (en) * 2007-05-17 2008-11-27 Piramal Life Sciences Limited Tumor necrosis factor - alpha inhibitors
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
EP2152270B1 (en) 2007-06-08 2015-03-04 Janssen Pharmaceutica, N.V. Piperidine/piperazine derivatives
JP5443342B2 (ja) 2007-06-08 2014-03-19 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピペリジン/ピペラジン誘導体
ES2483898T3 (es) 2007-06-08 2014-08-08 Janssen Pharmaceutica, N.V. Derivados de piperidina/piperazina
NZ589634A (en) * 2008-06-04 2012-09-28 Resmed Ltd A mask to apply positive airway pressure (PAP) for the treatment of a sleep disorder that attaches to the face
PE20100083A1 (es) 2008-06-05 2010-02-17 Janssen Pharmaceutica Nv Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
US20140182600A1 (en) * 2012-12-27 2014-07-03 3M Innovative Properties Company Filtering face-piece respirator having welded indicia hidden in pleat
WO2017210545A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
EP3571193B1 (en) 2017-01-23 2021-12-01 Cadent Therapeutics, Inc. Potassium channel modulators
JP7337174B2 (ja) 2018-09-18 2023-09-01 ニカング セラピューティクス, インコーポレイテッド Srcホモロジー-2ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体
MX2021004647A (es) 2018-10-22 2021-08-16 Novartis Ag Formas cristalinas de moduladores de los canales de potasio.
PH12022551379A1 (en) 2019-12-06 2023-05-03 Vertex Pharma Substituted tetrahydrofurans as modulators of sodium channels
AU2021342568B2 (en) 2020-09-21 2025-04-03 Landos Biopharma, Inc. Nlrx1 ligands
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1428186A (en) * 1972-06-21 1976-03-17 Fujisawa Pharmaceutical Co Chromone derivatives
US3937837A (en) 1972-12-04 1976-02-10 Warner-Lambert Company Substituted chromone-3-carbonitriles, carboxamides and carboxylic acids useful for preventing asthmatic symptoms
US3862143A (en) 1972-12-04 1975-01-21 Warner Lambert Co Substituted chromone-3-carbonitriles, carboxamides and carboxylic acids
DE2731566A1 (de) 1977-07-13 1979-02-01 Bayer Ag Verfahren zur herstellung von neuen chromon-derivaten, sowie ihre verwendung als pflanzenschutzmittel
FR2453170A1 (fr) * 1979-04-06 1980-10-31 Clin Midy Acides 5-(2-hydroxy-3-thiopropoxy)chromone-2-carboxyliques et leurs applications comme medicaments presentant notamment des proprietes antianaphylactiques et antiallergiques
EP0104018A3 (en) * 1982-09-21 1985-06-26 FISONS plc Benzopyran, benzothiapyran and quinoline compounds and pharmaceutical compositions containing them
DE3413007A1 (de) * 1984-04-06 1985-10-17 Audi AG, 8070 Ingolstadt Lenkeinrichtung fuer ein kraftfahrzeug
ATE56007T1 (de) 1984-06-22 1990-09-15 Beecham Group Plc Wirksame benzopyranverbindungen.
GB8515389D0 (en) 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
IT1190405B (it) 1985-10-22 1988-02-16 Recordati Chem Pharm Derivati del flavone
US5112856A (en) * 1986-08-15 1992-05-12 Hoffmann-La Roche Inc. Therapeutic treatment of intestinal inflammation by administration of 3,4-dihydro-2H-1-benzopyran derivatives
US5387587A (en) 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5171865A (en) 1988-02-29 1992-12-15 Sanwa Kagaku Kenkyusho Co., Ltd. Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
AU627027B2 (en) 1989-04-27 1992-08-13 Pharmacia & Upjohn Company Substituted 3-amino chromans
US5420151A (en) 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
SE8904361D0 (sv) 1989-12-22 1989-12-22 Astra Ab New chroman and thiochroman derivatives
DE4140542A1 (de) 1991-12-09 1993-06-17 Bayer Ag Piperdylmethyl substituierte chormanderivate
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
WO1994029293A1 (en) * 1993-06-10 1994-12-22 Yamanouchi Pharmaceutical Co., Ltd. Novel 8-(2-aminoalkoxy)fluorochroman derivative
WO1997007120A1 (en) 1995-08-11 1997-02-27 Smithkline Beecham Plc Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists
SE9601110D0 (sv) 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
CA2274055A1 (en) 1996-12-19 1998-06-25 Smithkline Beecham P.L.C. N-piperazin-1-ylphenyl-benzamide derivatives
AU7738298A (en) 1996-12-19 1998-07-15 Agrevo Uk Limited Chromones useful as fungicides
FR2760014B1 (fr) * 1997-02-27 1999-04-09 Adir Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2199645C (en) * 1997-03-11 1999-06-29 Apotex Inc. Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0874043A1 (de) * 1997-04-10 1998-10-28 Preussag AG Verfahren zur Herstellung von Biomasse mittels Photosynthese
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
JP2003524571A (ja) * 1997-07-25 2003-08-19 ハー・ルンドベック・アクチエゼルスカベット インドール−及び2,3−ジヒドロインドール誘導体、その製造方法及びその使用方法
SE9703378D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703379D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703377D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
WO1999051401A1 (en) * 1998-04-06 1999-10-14 Acs Industries Inc. Antimicrobial scrub pad
FR2782515B1 (fr) * 1998-08-21 2000-09-22 Adir NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
GB9818914D0 (en) 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
WO2000040554A1 (en) * 1999-01-07 2000-07-13 American Home Products Corporation Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
AU6866500A (en) * 1999-09-01 2001-03-26 Takeda Chemical Industries Ltd. Chromone derivatives, process for the preparation of the same and uses thereof
JP2001261657A (ja) 2000-03-17 2001-09-26 Yamanouchi Pharmaceut Co Ltd シアノフェニル誘導体
NZ535574A (en) 2001-01-16 2006-07-28 Astrazeneca Ab Therapeutic heterocyclic compounds
MXPA03006268A (es) 2001-01-16 2003-09-22 Astrazeneca Ab Compuestos terapeuticos de cromano.
SE0103649D0 (sv) 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic quinoline compounds

Similar Documents

Publication Publication Date Title
JP2004517130A5 (enExample)
AU656859B2 (en) Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent
CA2855204C (en) Benzimidazoles for the treatment and prevention of respiratory syncytial virus infection
CN1057051A (zh) 羟基和烷氧基吡啶衍生物
JP2004504348A5 (enExample)
CA2656415A1 (en) Novel pyridazine compound and use thereof
AU2018331172A1 (en) Influenza virus replication inhibitor and use thereof
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
CN109748915A (zh) 流感病毒复制抑制剂及其使用方法和用途
KR20040000412A (ko) 헤테로시클릭 화합물의 도파민-d3 리간드로서의 용도
JP2004517099A5 (enExample)
JP2003501474A5 (enExample)
KR940005566A (ko) 퀴놀린 화합물
JP2005505618A5 (enExample)
FI102752B (fi) Menetelmä verenpainetta alentavien 4-alkyyli-imidatsolijohdannaisten v almistamiseksi
NO793620L (no) Substituerte teofylliner, deres fremstilling og deres anvendelse
EP1125936A3 (en) Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases
JP2007538031A5 (enExample)
JP2005508969A5 (enExample)
JP3539926B2 (ja) 抗ウイルス性ピリミジンジオン誘導体及びそれらの製造方法
RU2004117595A (ru) Производные пиридина в качестве лигандов рецептора nmda
JP2005511559A5 (enExample)
JP2002538117A (ja) 肥満の予防または治療のための医薬の製造のための多環2−アミノチアゾール系の使用
JP2006503056A5 (enExample)
JP2000508299A (ja) 抗ウイルス作用を有する置換キノリン誘導体